A national warning reaches beyond the hospital ward
Pakistan faces more than 200,000 deaths a year linked to antimicrobial resistance, according to the World Health Organization (WHO) and the National Institute of Health (NIH), which are calling for coordinated action across hospitals, pharmacies, farms and environmental agencies.
Contents
- A national warning reaches beyond the hospital ward
- What the death estimates mean
- A priority list gives Pakistan a focus
- Why prescribing and pharmacy sales matter
- Regulation depends on provincial enforcement
- Farms and wastewater are part of the same problem
- Typhoid shows how treatment choices can shrink
- Better laboratories need better information sharing
- From awareness walks to daily decisions
- Key Points
In a statement dated 18 November 2026, the organisations put the annual toll at close to 40,000 deaths directly attributable to resistance and more than 160,000 additional associated deaths. Their warning follows Pakistan's announcement on 18 November 2025 of the first national priority pathogen list in WHO's Eastern Mediterranean Region, intended to guide action against infections that are becoming harder to treat.
The immediate problem is familiar: antibiotics bought without prescriptions, medicines prescribed unnecessarily, weak infection prevention and misuse in livestock and agriculture. Together, these practices give resistant germs more opportunities to survive and spread.
Antimicrobial resistance, or AMR, happens when bacteria, viruses, fungi and parasites stop responding to medicines intended to control them. Antibiotic resistance is the part of that problem involving bacteria. The germs become resistant, rather than the person taking the medicine.
For families, the consequences can mean an infection that lasts longer, a hospital stay that becomes more expensive, or treatment options that run out. For health authorities, the challenge is to connect decisions made in very different places: a doctor's consulting room, a pharmacy, a poultry farm and a wastewater system.
The latest appeal centres on One Health, an approach that treats human, animal and environmental health as connected. Pakistan's National Action Plan 2.0 on AMR puts surveillance, public education and infection prevention at the centre of that response.
What the death estimates mean
WHO and NIH present the current figures in their November 2026 statement. A death directly attributable to resistance is one estimated to have been avoided if the infection had responded to treatment. An associated death is a broader measure involving a person with a resistant infection.
The statement describes the current total as close to 40,000 directly attributable deaths plus more than 160,000 associated deaths. For 2050, it gives projections of 63,000 directly attributable deaths and 262,000 associated deaths annually without urgent measures. Those future measures should be presented separately, rather than combined into a new total.
The projected direct toll of 63,000 is about 58% higher than the current estimate of roughly 40,000. That comparison shows the scale of the increase Pakistan could face if prevention, prescribing and treatment do not improve.
Officials speaking around the 2024 National Antimicrobial Stewardship Summit gave higher estimates, putting deaths due to resistant bacteria at around 300,000 and deaths to which AMR contributed at 700,000 annually. Microbiologist Dr Syeda Sadaf Akbar has also estimated 200,000 to 300,000 direct and indirect deaths. WHO and NIH's current national warning uses the figure of more than 200,000.
A priority list gives Pakistan a focus
NIH and WHO announced Pakistan's national priority pathogen list in Islamabad on 18 November 2025. WHO's 2025 announcement described it as the first in the Eastern Mediterranean Region and among the first eight such national lists worldwide.
A pathogen is a microorganism that can cause disease. A priority list helps health authorities decide which threats deserve the most attention in laboratory testing, monitoring and research. Its practical value depends on whether hospitals and laboratories can identify resistant organisms and share usable information.
Pakistan's response has developed through several steps:
- September 2024: regulators and infectious disease specialists called for stronger controls on antibiotic sales and prescribing.
- 2024: the National Antimicrobial Stewardship Summit brought together more than 1,400 healthcare professionals.
- 18 November 2025: NIH and WHO announced the national priority pathogen list.
- 18 November 2026: WHO and NIH renewed their appeal for action across human, animal and environmental health.
- 2050: the horizon for the warning of 63,000 directly attributable and 262,000 associated deaths annually.
Why prescribing and pharmacy sales matter
NIH Chief Executive Officer Dr Muhammad Salman has identified inappropriate prescribing, antibiotic sales without prescriptions, poor infection prevention and misuse in agriculture and livestock as major drivers of resistance.
At a Karachi workshop covered on 23 September 2024, Salman described a survey of 11 major Pakistani hospitals in which 92% of admitted patients were prescribed antibiotics. He called for funding to put the national response into practice, including monitoring antibiotic use in healthcare and poultry production.
Antimicrobial stewardship means choosing these medicines carefully: prescribing them when needed, selecting an appropriate drug and dose, and reviewing treatment as clinical findings and test results become available. It requires action by prescribers and health institutions as well as patients.
Prof Shahzad Ali Khan, vice chancellor of the Health Services Academy in Islamabad, identified several contributing practices at the 2024 summit:
Self-medication, unjustified prescription of antibiotics by quacks and physicians, taking antibiotics for a shorter duration, and the production of substandard antibiotics by some companies are some of the major causes of antimicrobial resistance,
Patients need clear instructions from qualified professionals about whether an antibiotic is necessary and how long to take it. Antibiotics treat bacterial infections, not viral illnesses such as colds and influenza.
Regulation depends on provincial enforcement
Drug Regulatory Authority of Pakistan Chief Executive Officer Asim Rauf said in September 2024 that instructions to provincial health departments to ensure prescription requirements were being weakly enforced. He described medicine sales as a provincial responsibility, placing provincial authorities at the centre of implementation.
Dr Faisal Sultan, an infectious disease specialist, former special assistant to the prime minister on health and chief executive of Shaukat Khanum Memorial Hospital, proposed a unified prescription application to help regulate antibiotic sales nationwide.
Rauf also said the regulator intended to act against pharmaceutical companies using unethical marketing practices that encouraged excessive prescribing. The proposals address different points in the same chain: how medicines are promoted, how clinicians prescribe them and how pharmacies dispense them.
Pakistan consumed antibiotics worth Rs126 billion in 2023, according to figures presented around the 2024 stewardship summit. At the September workshop, DRAP quality assurance director Dr Obaidullah said the country had imported more than 3,000 metric tonnes of antibiotic raw material in 2019. The figures show the scale of the medicine supply that regulators must oversee.
Farms and wastewater are part of the same problem
Antimicrobial use in livestock, poultry, aquaculture and agriculture creates opportunities for resistant organisms to emerge beyond hospitals. Agricultural runoff, contaminated wastewater and poorly managed waste can then help those organisms move through the environment.
Salman explained the reasoning behind a shared response in WHO's 2025 announcement:
Combating antimicrobial resistance requires a comprehensive One Health approach that addresses the interconnectedness of human, animal and environmental health. Factors driving resistance in Pakistan include irrational prescribing practices, over-the-counter sales of antibiotics, poor infection prevention and control practices, and the misuse of antimicrobials in agriculture and livestock,
For Pakistan, this means improving veterinary prescribing and medicine oversight alongside controls in human healthcare. It also means including water, sanitation and waste management in efforts to prevent resistant infections.
Dr Zeeshan Iqbal Baig, national lead for the UK Health Security Agency, called in the 2026 campaign for responsible antimicrobial use and a coordinated One Health response. Dr Pawin Padungtod, One Health team lead at FAO Pakistan, described the awareness walk as a shared commitment by government and partners to collective action.
The practical task is to connect those commitments: information about antibiotic use in animals needs to inform the same national response that tracks resistant infections in patients.
Typhoid shows how treatment choices can shrink
Sindh's outbreak of extensively drug resistant typhoid provides a concrete example of what happens when a familiar disease becomes harder to treat. Doctors in Hyderabad began reporting cases in November 2016 that resisted conventional initial treatments as well as ceftriaxone, a widely used injectable antibiotic.
Sindh recorded 11 cases in the final two months of 2016, 730 in 2017 and 4,825 in 2018. By August 2019, the outbreak had reached 10,365 cases across 23 districts, with approximately two thirds reported in Karachi. The strain subsequently reached other parts of Pakistan and travellers carried it abroad.
Extensively drug resistant, shortened to XDR, means the organism resists several important treatment options. At the time of the outbreak, WHO identified azithromycin as the only reliable and affordable oral antibiotic remaining for the strain.
Prof Javed Akram, a former Punjab health minister and president of the Pakistan Society of Internal Medicine, cited XDR typhoid and multidrug resistant tuberculosis at the 2024 summit as examples of infections becoming extremely difficult to treat. Paediatrician and public health scientist Prof Zulfiqar Bhutta urged parents to have children vaccinated against typhoid, placing prevention alongside responsible medicine use.
Better laboratories need better information sharing
Pakistan's National Action Plan 2.0 prioritises surveillance across human and animal health, education for professionals and the public, and stricter infection prevention in healthcare facilities. Surveillance means collecting and examining information so authorities can identify where resistance is spreading and which treatments are losing effectiveness.
The national AMR plan covers 2024 to 2029. Support from the UK's Fleming Fund has helped laboratories and surveillance networks, while WHO, NIH, UKHSA and FAO have promoted stronger diagnostic capacity and coordination. Laboratory testing can help doctors identify the organism causing an infection and determine which medicines are likely to work.
Pakistan also faces a wider coordination problem. After the NIH reform law required a disease unit to manage major infectious disease programmes, officials said in October 2026 that programmes for polio, HIV, tuberculosis, malaria and hepatitis still operated through separate chains of command and did not routinely share integrated data with NIH.
AMR monitoring needs information to travel across those institutional boundaries. Hospitals, laboratories, animal health services and environmental authorities need compatible reporting arrangements, clear responsibilities and secure handling of patient and surveillance data.
Universities and researchers can contribute by studying resistant organisms, assessing infection prevention measures and examining environmental routes of spread. Audits of antibiotic procurement and use can also help institutions identify where prescribing practices need review.
From awareness walks to daily decisions
WHO, NIH, UKHSA and FAO launched the November 2026 awareness campaign with students and civil society under the theme "One Health, one action: Prevent AMR now". The previous year's theme was "Act Now: Protect Our Present, Secure Our Future", and included awards for students who designed posters about responsible antibiotic use.
WHO Representative in Pakistan Dr Luo Dapeng used the 2025 event to describe the urgency:
Antimicrobial resistance is not a distant problem. It is happening now. As we speak, every 5 minutes, 2 people die due to antimicrobial resistance or associated reasons in Pakistan. These deaths are preventable,
For families, the campaign's immediate message is to use antibiotics only when genuinely needed and under appropriate medical guidance. For clinicians, pharmacists and veterinarians, it is to make responsible prescribing and dispensing routine. For authorities, it is to fund diagnostics, enforce sales rules and prevent infections before treatment becomes necessary.
The 2026 statement gives no new implementation deadline, funding total or enforcement timetable. Pakistan's 2024 to 2029 plan provides the current policy window for turning those commitments into functioning surveillance, safer prescribing and stronger infection prevention.
Key Points
- WHO and NIH link more than 200,000 deaths annually in Pakistan to antimicrobial resistance.
- Their current warning includes close to 40,000 directly attributable deaths and more than 160,000 additional associated deaths.
- Without urgent measures, the projected direct annual toll could reach 63,000 by 2050.
- Pakistan announced the Eastern Mediterranean Region's first national priority pathogen list in November 2025.
- Key priorities include prescription controls, better diagnostics, infection prevention and responsible antimicrobial use in animals.
- The national response depends on connecting human, animal and environmental health information and action.






